Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial – medRxiv Commentary: Study finds no benefit to taking ivermectin for COVID-19 symptoms – Duke University  

The post [Preprint] RCT: Ivermectin does not benefit patients with mild-to-moderate COVID-19 in the outpatient setting. appeared first on Links Medicus.